REFERENCES

1. Turroni F, Sinderen D, Ventura M. Genomics and ecological overview of the genus Bifidobacterium. Int J Food Microbiol 2011;149:37-44.

2. Fushinobu S. Unique sugar metabolic pathways of bifidobacteria. Biosci Biotechnol Biochem 2010;74:2374-84.

3. Sharma M, Wasan A, Sharma RK. Recent developments in probiotics: an emphasis on Bifidobacterium. Food Biosci 2021;41:100993.

4. Kelly SM, Munoz-Munoz J, van Sinderen D. Plant glycan metabolism by Bifidobacteria. Front Microbiol 2021;12:609418.

5. Sakanaka M, Gotoh A, Yoshida K, et al. Varied pathways of infant gut-associated Bifidobacterium to assimilate human milk oligosaccharides: prevalence of the gene set and its correlation with bifidobacteria-rich microbiota formation. Nutrients 2019;12:71.

6. Sakanaka M, Hansen ME, Gotoh A, et al. Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis. Sci Adv 2019;5:eaaw7696.

7. Martinez FA, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP. Bacteriocin production by Bifidobacterium spp. a review. Biotechnol Adv 2013;31:482-8.

8. Zavaglia A, Kociubinski G, Pérez P, Disalvo E, De Antoni G. Effect of bile on the lipid composition and surface properties of bifidobacteria. J Appl Microbiol 2002;93:794-9.

9. Mawatari S, Sasuga Y, Morisaki T, et al. Identification of plasmalogens in Bifidobacterium longum, but not in Bifidobacterium animalis. Sci Rep 2020;10:427.

10. Fontes AL, Pimentel L, Rodríguez-Alcalá LM, Gomes A. Effect of pufa substrates on fatty acid profile of Bifidobacterium breve Ncimb 702258 and CLA/CLNA production in commercial semi-skimmed milk. Sci Rep 2018;8:15591.

11. Liu S, Ren F, Jiang J, Zhao L. Acid response of Bifidobacterium longum subsp. longum BBMN68 is accompanied by modification of the cell membrane fatty acid composition. J Microbiol Biotechnol 2016;26:1190-7.

12. O'Connell KJ, Motherway MO, Hennessey AA, et al. Identification and characterization of an oleate hydratase-encoding gene from Bifidobacterium breve. Bioengineered 2013;4:313-21.

13. Veerkamp JH. Fatty acid composition of Bifidobacterium and Lactobacillus strains. J Bacteriol 1971;108:861-7.

14. Argudín M, Mendoza MC, Rodicio MR. Food poisoning and Staphylococcus aureus enterotoxins. Toxins 2010;2:1751-73.

15. Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol 2018;26:484-97.

16. McClelland RS, Fowler VG, Jr. , Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med 1999;159:1244-7.

17. Miyano T, Irvine AD, Tanaka RJ. Model-based meta-analysis to optimize Staphylococcus aureus-targeted therapies for atopic dermatitis. JID Innov 2022;2:100110.

18. Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 2015;42:756-66.

19. Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012;22:850-9.

20. Iwamoto K, Moriwaki M, Miyake R, Hide M. Staphylococcus aureus in atopic dermatitis: strain-specific cell wall proteins and skin immunity. Allergol Int 2019;68:309-15.

21. Cogen AL, Yamasaki K, Sanchez KM, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 2010;130:192-200.

22. Iwase T, Uehara Y, Shinji H, et al. staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 2010;465:346-9.

23. Lai Y, Cogen AL, Radek KA, et al. Activation of TLR2 by a small molecule produced by staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 2010;130:2211-21.

24. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009;15:1377-82.

25. Peng G, Tsukamoto S, Ikutama R, et al. Human β-defensin-3 attenuates atopic dermatitis-like inflammation through autophagy activation and the aryl hydrocarbon receptor signaling pathway. J Clin Invest 2022:132.

26. Jang IT, Yang M, Kim HJ, Park JK. Novel cytoplasmic bacteriocin compounds derived from staphylococcus epidermidis selectively kill Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). Pathogens 2020;9:87.

27. Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med 2017;9:eaah4680.

28. Cartron ML, England SR, Chiriac AI, et al. Bactericidal activity of the human skin fatty acid cis-6-hexadecanoic acid on Staphylococcus aureus. Antimicrob Agents Chemother 2014;58:3599-609.

29. Kenny JG, Ward D, Josefsson E, et al. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 2009;4:e4344.

30. Neumann Y, Ohlsen K, Donat S, et al. The effect of skin fatty acids on Staphylococcus aureus. Arch Microbiol 2015;197:245-67.

31. Watanabe T, Yamamoto Y, Miura M, et al. Systematic analysis of selective bactericidal activity of fatty acids against Staphylococcus aureus with minimum inhibitory concentration and minimum bactericidal concentration. J Oleo Sci 2019;68:291-6.

32. Schäfer L, Kragballe K. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis. J Invest Dermatol 1991;96:10-5.

33. Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G. Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by Staphylococcus aureus. Dermatology 2005;211:240-8.

34. Kikukawa H, Sakuradani E, Ando A, et al. Microbial production of dihomo-γ-linolenic acid by Δ5-desaturase gene-disruptants of Mortierella alpina 1S-4. J Biosci Bioeng 2016;122:22-6.

35. Kikukawa H, Sakuradani E, Kishino S, et al. Characterization of a trifunctional fatty acid desaturase from oleaginous filamentous fungus Mortierella alpina 1S-4 using a yeast expression system. J Biosci Bioeng 2013;116:672-6.

36. Kikukawa H, Shimizu C, Hirono-Hara Y, Hara KY. Screening of plant oils promoting growth of the red yeast Xanthophyllomyces dendrorhous with astaxanthin and fatty acid production. Biocatal Agric Biotechnol 2021;35:102101.

37. Takashima S, Toyoshi K, Yamamoto T, Shimozawa N. Positional determination of the carbon-carbon double bonds in unsaturated fatty acids mediated by solvent plasmatization using LC-MS. Sci Rep 2020;10:12988.

38. Mori T, Yoshida M, Hazekawa M, et al. Antimicrobial activities of LL-37 fragment mutant-poly (lactic-co-glycolic) acid conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans. Int J Mol Sci 2021;22:5097.

39. Fujita Y, Matsuoka H, Hirooka K. Regulation of fatty acid metabolism in bacteria. Mol Microbiol 2007;66:829-39.

40. Nagao T, Watanabe Y, Hiraoka K, et al. Microbial conversion of vegetable oil to rare unsaturated fatty acids and fatty alcohols by an Aeromonas hydrophila isolate. J Am Oil Chem Soc 2009;86:1189.

41. Guerzoni ME, Lanciotti R, Cocconcelli PS. Alteration in cellular fatty acid composition as a response to salt, acid, oxidative and thermal stresses in Lactobacillus helveticus. Microbiology 2001;147:2255-64.

42. Rozès N, Peres C. Effects of phenolic compounds on the growth and the fatty acid composition of Lactobacillus plantarum. Appl Microbiol Biotechnol 1998;49:108-11.

43. Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 2010;85:1629-42.

44. Parsons JB, Yao J, Frank MW, Jackson P, Rock CO. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J Bacteriol 2012;194:5294-304.

45. Tiwari KB, Gatto C, Wilkinson BJ. Plasticity of coagulase-negative staphylococcal membrane fatty acid composition and implications for responses to antimicrobial agents. Antibiotics 2020;9:214.

46. Nagao T, Tanaka S, Yamashita K, et al. Methods of production of lipids and fatty acids, and the fatty acid compositions; 0. Japanese Patent; 2020. Available from: https://www.j-platpat.inpit.go.jp/c1800/PU/JP-2020-005614/451E2C19D56321EF3C3A3B19680D315C98390CD272BDB07915F3D07699BAB143/11/ja[Last accessed on 16 Feb 2023].

47. Okukawa M, Yoshizaki Y, Yano S, Nonomura Y. The selective antibacterial activity of the mixed systems containing myristic acid against staphylococci. J Oleo Sci 2021;70:1239-46.

48. Cau L, Williams MR, Butcher AM, et al. staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis. J Allergy Clin Immunol 2021;147:955-66.e16.

49. Nagao T, Uyama A, Sugino T, Tanaka S, Kishimoto N. Control of skin microbiota with fatty acids: Rethinking the removal of “all” skin microorganisms. Available from: https://www.aocs.org/documents/InformPDF/INFORM_January_2020.pdf[Last accessed on 16 Feb 2023].

Microbiome Research Reports
ISSN 2771-5965 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/